Aralıklı Oruç

Wu, S., et al., Evaluating intrinsic and non-intrinsic cancer risk factors. Nature communications, 2018. 9(1): p. 3490.
Grosso, G., et al., Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutrition reviews, 2017. 75(6): p. 405-419.
Güveli, H., et al., Onkoloji hastalarında tamamlayıcı ve alternatif tıp kullanım sıklığının ve diyet yaklaşımlarının belirlenmesi. Avrupa Bilim ve Teknoloji Dergisi, 2021(21): p. 307-312.
Longo, V.D. and L. Fontana, Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends in pharmacological sciences, 2010. 31(2): p. 89-98.
Kerndt, P.R., et al., Fasting: the history, pathophysiology and complications. Western Journal of Medicine, 1982. 137(5): p. 379.
Hoddy, K.K., et al., Intermittent fasting and metabolic health: from religious fast to time‐restricted feeding. Obesity, 2020. 28: p. S29-S37.
Moro, T., et al., Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. Journal of translational medicine, 2016. 14(1): p. 1-10.
Patterson, R.E., et al., Intermittent fasting and human metabolic health. Journal of the Academy of Nutrition and Dietetics, 2015. 115(8): p. 1203.
Zubrzycki, A., et al., The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. Journal of Physiology & Pharmacology, 2018. 69(5).
Bhutani, S., et al., Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity, 2013. 21(7): p. 1370-1379.
Barnosky, A.R., et al., Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. Translational Research, 2014. 164(4): p. 302-311.
Varady, K.A. and M.K. Hellerstein, Alternate-day fasting and chronic disease prevention: a review of human and animal trials. The American journal of clinical nutrition, 2007. 86(1): p. 7-13.
Varady, K.A., et al., Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. The American journal of clinical nutrition, 2009. 90(5): p. 1138-1143.
Kacimi, S., et al., Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutrition research, 2012. 32(12): p. 947-955.
Ziegler, D.R., et al., Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochemical research, 2003. 28: p. 1793-1797.
Alirezaei, M., et al., Short-term fasting induces profound neuronal autophagy. Autophagy, 2010. 6(6): p. 702-710.
Mattson, M.P., V.D. Longo, and M. Harvie, Impact of intermittent fasting on health and disease processes. Ageing research reviews, 2017. 39: p. 46-58.
Salvadori, G., M.G. Mirisola, and V.D. Longo, Intermittent and periodic fasting, hormones, and cancer prevention. Cancers, 2021. 13(18): p. 4587.
Wei, M., et al., Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Science translational medicine, 2017. 9(377): p. eaai8700.
Sadeghian, M., et al., A review of fasting effects on the response of cancer to chemotherapy. Clinical nutrition, 2021. 40(4): p. 1669-1681.
O’Flanagan, C.H., et al., When less may be more: calorie restriction and response to cancer therapy. BMC medicine, 2017. 15: p. 1-9.
Mindikoglu, A.L., et al., Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. Journal of proteomics, 2020. 217: p. 103645.
Fettig, L.M. and D. Yee, Advances in insulin-like growth factor biology and-directed cancer therapeutics. Advances in cancer research, 2020. 147: p. 229-257.
de Groot, S., et al., The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC cancer, 2015. 15(1): p. 1-9.
de Groot, S., et al., Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature communications, 2020. 11(1): p. 3083.
Zorn, S.M., et al., Impact of modified short-term fasting and the combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients–a randomised controlled cross-over pilot study. 2020.
Bauersfeld, S.P., et al., The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC cancer, 2018. 18: p. 1-10.
Anemoulis, M., et al., Intermittent Fasting in Breast Cancer: A Systematic Review and Critical Update of Available Studies. Nutrients, 2023. 15(3): p. 532.
Psara, E., et al., Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2023. 23(17): p. 1889-1909.